Michael Powell - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Checkmate Pharmaceuticals Inc (CMPI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Checkmate Pharmaceuticals Inc (CMPI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Checkmate Pharmaceuticals Inc (CMPI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Inozyme Pharma Inc (INZY). Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net purchase of 1,833,697 shares made by Robert Lorne Hopfner , a net purchase of 833,333 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. , and a net sale of 7,523 shares made by Douglas A Treco .

In summary, during the past 3 months, insiders sold 0 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,523 shares of Inozyme Pharma Inc (INZY) were sold and 2,667,030 shares were bought by its insiders, resulting in a net purchase of 2,659,507 shares.

Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Akouos Inc (AKUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akouos Inc (AKUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Akouos Inc (AKUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Galera Therapeutics Inc (GRTX). Other recent insider transactions involving Galera Therapeutics Inc (GRTX) include a net purchase of 3,712,809 shares made by , and a net sale of 67,015 shares made by Mel Sorensen .

In summary, during the past 3 months, insiders sold 67,015 shares of Galera Therapeutics Inc (GRTX) in total and bought 0 shares, with a net sale of 67,015 shares. During the past 18 months, 67,015 shares of Galera Therapeutics Inc (GRTX) were sold and 3,712,809 shares were bought by its insiders, resulting in a net purchase of 3,645,794 shares.

Galera Therapeutics Inc (GRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Iterum Therapeutics PLC (ITRM). Other recent insider transactions involving Iterum Therapeutics PLC (ITRM) include a net purchase of 55,000 shares made by Michael W. Dunne , and a net purchase of 10,000 shares made by Fishman Corey N. .

In summary, during the past 3 months, insiders sold 0 shares of Iterum Therapeutics PLC (ITRM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Iterum Therapeutics PLC (ITRM) were sold and 65,000 shares were bought by its insiders, resulting in a net purchase of 65,000 shares.

Iterum Therapeutics PLC (ITRM)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of NextCure Inc (NXTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NextCure Inc (NXTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NextCure Inc (NXTC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Synlogic Inc (SYBX). Other recent insider transactions involving Synlogic Inc (SYBX) include a net sale of 6,810 shares made by Antoine Awad , a net sale of 19,042 shares made by Aoife Brennan , and a net sale of 2,553 shares made by Michael Vangsted Jensen .

In summary, during the past 3 months, insiders sold 0 shares of Synlogic Inc (SYBX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,429 shares of Synlogic Inc (SYBX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,429 shares.

Synlogic Inc (SYBX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Entasis Therapeutics Holdings Inc (ETTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Entasis Therapeutics Holdings Inc (ETTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Entasis Therapeutics Holdings Inc (ETTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Ocera Therapeutics Inc (OCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ocera Therapeutics Inc (OCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ocera Therapeutics Inc (OCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Marinus Pharmaceuticals Inc (MRNS). Other recent insider transactions involving Marinus Pharmaceuticals Inc (MRNS) include a net sale of 18,588 shares made by Scott Braunstein , a net sale of 7,730 shares made by Joseph Hulihan , and a net sale of 7,461 shares made by Steven Pfanstiel .

In summary, during the past 3 months, insiders sold 29,071 shares of Marinus Pharmaceuticals Inc (MRNS) in total and bought 0 shares, with a net sale of 29,071 shares. During the past 18 months, 45,796 shares of Marinus Pharmaceuticals Inc (MRNS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 45,796 shares.

Marinus Pharmaceuticals Inc (MRNS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Aclaris Therapeutics Inc (ACRS). Other recent insider transactions involving Aclaris Therapeutics Inc (ACRS) include a net purchase of 4,854,052 shares made by Braden Michael Leonard , a net sale of 18,000 shares made by Joseph Monahan , and a net purchase of 14,705 shares made by James Loerop .

In summary, during the past 3 months, insiders sold 0 shares of Aclaris Therapeutics Inc (ACRS) in total and bought 2,697,852 shares, with a net purchase of 2,697,852 shares. During the past 18 months, 18,000 shares of Aclaris Therapeutics Inc (ACRS) were sold and 4,878,247 shares were bought by its insiders, resulting in a net purchase of 4,860,247 shares.

Aclaris Therapeutics Inc (ACRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in aTyr Pharma Inc (ATYR). Other recent insider transactions involving aTyr Pharma Inc (ATYR) include a net purchase of 65,000 shares made by Sanjay Shukla , a net purchase of 300,000 shares made by Paul Schimmel , and a net purchase of 3,410 shares made by Jill Marie Broadfoot .

In summary, during the past 3 months, insiders sold 0 shares of aTyr Pharma Inc (ATYR) in total and bought 100,000 shares, with a net purchase of 100,000 shares. During the past 18 months, 1,590 shares of aTyr Pharma Inc (ATYR) were sold and 425,000 shares were bought by its insiders, resulting in a net purchase of 423,410 shares.

aTyr Pharma Inc (ATYR)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Spark Therapeutics Inc (ONCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Spark Therapeutics Inc (ONCE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Spark Therapeutics Inc (ONCE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Ocugen Inc (OCGN). Other recent insider transactions involving Ocugen Inc (OCGN) include a net purchase of 200,278 shares made by Junge Zhang ,

In summary, during the past 3 months, insiders sold 0 shares of Ocugen Inc (OCGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ocugen Inc (OCGN) were sold and 200,278 shares were bought by its insiders, resulting in a net purchase of 200,278 shares.

Ocugen Inc (OCGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Alimera Sciences Inc (ALIM). Other recent insider transactions involving Alimera Sciences Inc (ALIM) include a net sale of 0 shares made by Caligan Partners Lp , a net purchase of 1,401,901 shares made by Adam Morgan , and a net sale of 200,919 shares made by Palo Alto Investors, Llc .

In summary, during the past 3 months, insiders sold 0 shares of Alimera Sciences Inc (ALIM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 779,919 shares of Alimera Sciences Inc (ALIM) were sold and 1,980,901 shares were bought by its insiders, resulting in a net purchase of 1,200,982 shares.

Alimera Sciences Inc (ALIM)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Aerie Pharmaceuticals Inc (AERI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerie Pharmaceuticals Inc (AERI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aerie Pharmaceuticals Inc (AERI)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Aravive Inc (ARAV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aravive Inc (ARAV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aravive Inc (ARAV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Humanigen Inc (HGENQ). Other recent insider transactions involving Humanigen Inc (HGENQ) include a net sale of 386,350 shares made by Dale Chappell ,

In summary, during the past 3 months, insiders sold 0 shares of Humanigen Inc (HGENQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 386,350 shares of Humanigen Inc (HGENQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 386,350 shares.

Humanigen Inc (HGENQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Anthera Pharmaceuticals Inc (ANTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Anthera Pharmaceuticals Inc (ANTH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Anthera Pharmaceuticals Inc (ANTH)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Orexigen Therapeutics Inc (OREXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Orexigen Therapeutics Inc (OREXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Orexigen Therapeutics Inc (OREXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Amarin Corp PLC (AMRN). Other recent insider transactions involving Amarin Corp PLC (AMRN) include a net purchase of 314,426 shares made by Patrick Holt , a net purchase of 160,000 shares made by Aaron Berg , and a net sale of 34,131 shares made by Steven B Ketchum .

In summary, during the past 3 months, insiders sold 0 shares of Amarin Corp PLC (AMRN) in total and bought 160,000 shares, with a net purchase of 160,000 shares. During the past 18 months, 34,131 shares of Amarin Corp PLC (AMRN) were sold and 474,426 shares were bought by its insiders, resulting in a net purchase of 440,295 shares.

Amarin Corp PLC (AMRN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Molecular Templates Inc (MTEM). Other recent insider transactions involving Molecular Templates Inc (MTEM) include a net purchase of 4,505,319 shares made by Biotech Target N V ,

In summary, during the past 3 months, insiders sold 0 shares of Molecular Templates Inc (MTEM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Molecular Templates Inc (MTEM) were sold and 533,688 shares were bought by its insiders, resulting in a net purchase of 533,688 shares.

Molecular Templates Inc (MTEM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Paratek Pharmaceuticals Inc (PRTK). Other recent insider transactions involving Paratek Pharmaceuticals Inc (PRTK) include a net purchase of 788,500 shares made by James D Dondero , a net sale of 48,967 shares made by Evan Loh , and a net sale of 34,526 shares made by William M. Haskel .

In summary, during the past 3 months, insiders sold 0 shares of Paratek Pharmaceuticals Inc (PRTK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 142,346 shares of Paratek Pharmaceuticals Inc (PRTK) were sold and 788,500 shares were bought by its insiders, resulting in a net purchase of 646,154 shares.

Paratek Pharmaceuticals Inc (PRTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Seagen Inc (SGEN). Other recent insider transactions involving Seagen Inc (SGEN) include a net sale of 36,274 shares made by Vaughn B Himes , a net sale of 2,228 shares made by Charles R Romp , and a net sale of 58,274 shares made by Todd E Simpson .

In summary, during the past 3 months, insiders sold 0 shares of Seagen Inc (SGEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 195,202 shares of Seagen Inc (SGEN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 195,202 shares.

Seagen Inc (SGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Bolt Biotherapeutics Inc (BOLT). Other recent insider transactions involving Bolt Biotherapeutics Inc (BOLT) include a net sale of 200,000 shares made by Edgar Engleman , a net sale of 89,454 shares made by Vivo Capital Fund Viii, L.p. , and a net purchase of 11,829 shares made by William P. Quinn .

In summary, during the past 3 months, insiders sold 0 shares of Bolt Biotherapeutics Inc (BOLT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 289,454 shares of Bolt Biotherapeutics Inc (BOLT) were sold and 11,829 shares were bought by its insiders, resulting in a net sale of 277,625 shares.

Bolt Biotherapeutics Inc (BOLT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Michael Powell made no insider transaction in Vera Therapeutics Inc (VERA). Other recent insider transactions involving Vera Therapeutics Inc (VERA) include a net sale of 81,251 shares made by Marshall Fordyce , a net purchase of 29,674 shares made by Beth C Seidenberg , and a net sale of 673,169 shares made by Maha Katabi .

In summary, during the past 3 months, insiders sold 76,041 shares of Vera Therapeutics Inc (VERA) in total and bought 0 shares, with a net sale of 76,041 shares. During the past 18 months, 2,092,881 shares of Vera Therapeutics Inc (VERA) were sold and 644,181 shares were bought by its insiders, resulting in a net sale of 1,448,700 shares.

Vera Therapeutics Inc (VERA)'s detailed insider trading history can be found in Insider Trading Tracker table.